KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 151 filers reported holding KITE PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $62,000 | +72.2% | 350 | 0.0% | 0.03% | +52.6% |
| Q2 2017 | $36,000 | +33.3% | 350 | 0.0% | 0.02% | +35.7% |
| Q1 2017 | $27,000 | +80.0% | 350 | 0.0% | 0.01% | +75.0% |
| Q4 2016 | $15,000 | -21.1% | 350 | 0.0% | 0.01% | -27.3% |
| Q3 2016 | $19,000 | +11.8% | 350 | 0.0% | 0.01% | +22.2% |
| Q2 2016 | $17,000 | +6.2% | 350 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $16,000 | -23.8% | 350 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $21,000 | +10.5% | 350 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $19,000 | -9.5% | 350 | 0.0% | 0.01% | -10.0% |
| Q2 2015 | $21,000 | +5.0% | 350 | 0.0% | 0.01% | +11.1% |
| Q1 2015 | $20,000 | 0.0% | 350 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $20,000 | +100.0% | 350 | 0.0% | 0.01% | +50.0% |
| Q3 2014 | $10,000 | – | 350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |